WADLEY MEDICAL CENTER AT HOPE
1. Target Overview & Investment Thesis
WADLEY MEDICAL CENTER AT HOPE is a 36-bed under-performing / distressed in HEMPSTEAD, AR with $13.1M in net patient revenue and a -24.4% operating margin. The hospital serves a payer mix of 41.7% Medicare, 6.6% Medicaid, and 51.7% commercial.
Thesis: Turnaround. Our ML models identify $965K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.4% to -17.1% (+738bps).
| Net Revenue HCRIS | $13.1M |
| Current EBITDA COMPUTED | $-3.2M |
| Operating Margin COMPUTED | -24.4% |
| Occupancy HCRIS | 9.2% |
| Revenue / Bed COMPUTED | $363K |
| Net-to-Gross HCRIS | 18.8% |
| Distress Probability ML | 58.5% |
2. Market Context & Competitive Position
AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -24.4% places it below the state median. Among 59 size-comparable peers (18-72 beds), the median margin is -13.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (18-72), prioritizing same-state peers. 59 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| WADLEY MEDICAL CENTER AT HOPE (Target) | AR | 36 | $13.1M | -24.4% |
| ARKANSAS CHILDRENS NORTHWEST | AR | 24 | $113.6M | 7.2% |
| SILOAM SPRINGS MEMORIAL HOSPIT | AR | 64 | $85.0M | 8.4% |
| ARKANSAS SURGICAL HOSPITAL | AR | 47 | $75.1M | 11.7% |
| ST VINCENT NORTH | AR | 68 | $72.1M | -18.7% |
| ENCORE MEDICAL CENTER | AR | 25 | $55.7M | -4.7% |
| OZARKS COMMUNITY HOSPITAL OF G | AR | 25 | $48.6M | -21.0% |
| DREW MEMORIAL HOSPITAL INC | AR | 49 | $35.3M | -27.2% |
| ASHLEY COUNTY MEDICAL CENTER | AR | 25 | $33.7M | -23.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $965K (738bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $275K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $262K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $260K | +199bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $159K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-3.2M |
| + RCM Uplift | +$965K |
| Pro Forma EBITDA | $-2.2M |
| Current Margin | -24.4% |
| Pro Forma Margin | -17.1% |
| WC Released (1x) | $502K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-4.9M | $-11.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-4.9M | $-14.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-4.4M | $-12.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-4.4M | $-15.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-5.4M | $-14.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-5.4M | $-17.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 9.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 58.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 59 hospitals with 18-72 beds
- Same-state prioritization (n=60)
- Comp margins: P25=-23.3% / P50=-13.9% / P75=2.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.